Latest filing published 18 Mar 2025 for Bio-Rad Laboratories, INC., €683k.
Filing timeline
BuySaleInsider track record
Michael Crowley: trading record in brief
All filings by Michael Crowley on record concern Bio-Rad Laboratories, Inc., in the capacity of senior executive. Between 10 March 2015 and 14 March 2025, the trades on record add up to 114 filings.
Every open-market trade on record is a sale: 25 sales worth €6.2M. Other entries cover 39 share grants and 50 option exercises. In 2025 alone, the filings show no purchases and 1 sale.
The newest entry dates from 18 March 2025: an open-market sale of €683k, in Bio-Rad Laboratories, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Michael Crowley
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 3,000 shares@ US$247.066.3% of flowBio-Rad A Common StockSEC:0001062993-25-005730:1
- 3,000 shares@ US$159.3223.9% of flowBio-Rad A Common StockSEC:0001062993-25-005730:0
- 520 shares0Bio-Rad A Common StockSEC:0001062993-24-016196:2
- 405 shares0Bio-Rad A Common StockSEC:0001062993-24-016196:4
- 434 shares0Bio-Rad A Common StockSEC:0001062993-24-016196:6
- 557 shares0Bio-Rad A Common StockSEC:0001062993-24-016196:8
- 268 shares@ US$337.320.8% of flowBio-Rad A Common StockSEC:0001062993-24-016196:1
- 218 shares@ US$337.320.6% of flowBio-Rad A Common StockSEC:0001062993-24-016196:3
- 145 shares@ US$337.320.4% of flowBio-Rad A Common StockSEC:0001062993-24-016196:5
- 155 shares@ US$337.320.4% of flowBio-Rad A Common StockSEC:0001062993-24-016196:7
- 283 shares@ US$334.310.8% of flowBio-Rad A Common StockSEC:0001062993-24-016196:9
- 751 shares0Bio-Rad A Common StockSEC:0001062993-24-016196:0
- 369 shares@ US$281.90645.3% of flowBio-Rad A Common StockSEC:0001062993-24-012628:0
- 3,000 shares@ US$336.008.6% of flowBio-Rad A Common StockSEC:0001062993-24-004835:1
- 3,000 shares@ US$215.9832.4% of flowBio-Rad A Common StockSEC:0001062993-24-004835:0
- 642 shares@ US$305.109.7% of flowBio-Rad A Common StockSEC:0001062993-23-021535:0
- 180 shares@ US$394.600.6% of flowBio-Rad A Common StockSEC:0001062993-23-017646:1
- 141 shares@ US$394.600.5% of flowBio-Rad A Common StockSEC:0001062993-23-017646:3
- 150 shares@ US$394.600.5% of flowBio-Rad A Common StockSEC:0001062993-23-017646:5
- 202 shares@ US$394.600.7% of flowBio-Rad A Common StockSEC:0001062993-23-017646:7
- 298 shares@ US$394.601.0% of flowBio-Rad A Common StockSEC:0001062993-23-017646:9
- 405 shares0Bio-Rad A Common StockSEC:0001062993-23-017646:2
- 433 shares0Bio-Rad A Common StockSEC:0001062993-23-017646:4
- 557 shares0Bio-Rad A Common StockSEC:0001062993-23-017646:6
- 600 shares0Bio-Rad A Common StockSEC:0001062993-23-017646:8
25 of 113 declarations
